BCL2 and neoplasm: In addition, inhibition of apoptosis via the Bcl-2 pathway [71], and the down-regulation of PMS2 and topoisomerase 11 DNA mismatch repair proteins [72], [73] have been proposed as mechanisms that desensitize tumor cells in spheroids to antitumor agents.